PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
Main Authors: | Folgori, A, Barnes, E, Aston, S, Smith, K, Brown, A, Ambrosio, M, Ammendola, V, Bartiromo, M, Capone, S, Naddeo, M, Sparacino, A, Siani, L, Traboni, C, Colloca, S, Nicosia, A, Cortese, R, Klenerman, P |
---|---|
Format: | Conference item |
Published: |
2009
|
Similar Items
-
PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
by: Barnes, E, et al.
Published: (2009) -
PHASE I TRIAL OF A HIGHLY IMMUNOGENIC AND DURABLE T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
by: Barnes, E, et al.
Published: (2011) -
A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
by: Kelly, C, et al.
Published: (2011) -
Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
by: Capone, S, et al.
Published: (2010) -
Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates.
by: Capone, S, et al.
Published: (2010)